Be the first to like this.
0 comment(s).
Post a Comment
Market Buzz
Featured Posts
Introducing MY's First IPO Fund for Sophisticated Investors!
New Update. Discover investment communities that resonate with your ideas
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
Apps
Top Articles
1
2
4
save malaysia!
Visa-free travel to China extended for Malaysians to 30 days
5
6
7
8
Good Articles to Share
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
MQ Trading Signals
Stock
Time
Signal
Duration
No trading signals available.
Stock
Time
Signal
Duration
No trading signals available.
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Posted by Peterng123 > 2021-04-21 09:55 | Report Abuse
We expect UEME’s earnings to grow robustly at 67% CAGR in 2021-23F as it stands to be the prime beneficiary of the economic reopening and healthcare industry growth, being among the major laggards in the market. This will support its dividend payout ratio of 70%, providing yields of 5-7% for 2021-23F, which is consistent with its dividend policy. It is also expected to be eligible for FTSE4Good Bursa Malaysia (F4GBM) Index inclusion this year. Initiate coverage with BUY. Target price: RM2.30. Find out more by clicking the link: https://research.uobkayhian.com/content_download.jsp?id=62055&h=5f6cf32c38c1ca47bb47534611d55824